# 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency

> **NCT04228445** · PHASE3 · COMPLETED · sponsor: **Prove pharm** · enrollment: 121 (actual)

## Conditions studied

- Ureter Injury

## Interventions

- **DRUG:** 3,3'-Dioxo-2,2'-bisindolylidene-5,5'-disulfonate disodium 0.8%
- **DRUG:** Saline spray

## Key facts

- **NCT ID:** NCT04228445
- **Lead sponsor:** Prove pharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-13
- **Primary completion:** 2021-06-03
- **Final completion:** 2021-06-03
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04228445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04228445, "3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04228445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*